Receptor Occupancy of Nonpeptide Corticotropin-Releasing Factor 1 Antagonist DMP696: Correlation with Drug Exposure and Anxiolytic Efficacy-Reference-Cited by-同舟云学术

Receptor Occupancy of Nonpeptide Corticotropin-Releasing Factor 1 Antagonist DMP696: Correlation with Drug Exposure and Anxiolytic Efficacy

Published:2003-01-21 Issue:1 Volume:305 Page:86-96
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Li Yu-Wen,Hill Geraldine,Wong Harvey,Kelly Natasha,Ward Kathryn,Pierdomenico Marie,Ren Shelly,Gilligan Paul,Grossman Scott,Trainor George,Taub Rebecca,McElroy John,Zazcek Robert

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference38 articles.

1. Corticotropin-releasing Factor Receptors: Distribution and Regulation in Brain, Pituitary, and Peripheral Tissues

2. Changes in Cerebrospinal Fluid Neurochemistry During Treatment of Obsessive-compulsive Disorder With Clomipramine

3. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154, 526: behavioral, endocrine and neurochemical effects in the rat.;Arborelius;J Pharmacol Exp Ther,2000

4. Bakthavatchalam R Arvanitis AG Gilligan PJ Olson RE Robertson DW Trainor G Smith SC Fitzgerald LW Zaczek R Shen H (1998) The discovery of DMP695: an orally active corticotropin-releasing hormone (CRF1) receptor antagonist. The 216th ACS National Meeting, Boston, MA, Aug 23–27; MEDI 134..

5. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder.;Bremner;Am J Psychiatry,1997

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of Purine Analogues: Photocatalyst-Free Visible-Light-Enhanced Annulation Approach to Pyrazolo[1,5-a][1,3,5]triazine-2,4-diamines;The Journal of Organic Chemistry;2021-06-07

2. Synthesis and evaluation of carbamate and aryl ether substituted pyrazinones as corticotropin releasing factor-1 (CRF1) receptor antagonists;Bioorganic & Medicinal Chemistry Letters;2016-05

3. Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor;Bioorganic & Medicinal Chemistry;2015-08

4. SSRI or CRF antagonism partially ameliorate depressive-like behavior after adolescent social defeat;Behavioural Brain Research;2014-08

5. Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors;Nuclear Medicine and Biology;2014-07